Ionis Pharmaceuticals (IONS) Work In Process (2019 - 2025)

Ionis Pharmaceuticals' Work In Process history runs 7 years deep, the most recent figure standing at $8.7 million for Q1 2025.

• In Q1 2025, Work In Process rose 44.84% year-over-year to $8.7 million; the TTM figure through Mar 2025 stood at $8.7 million (up 44.84% YoY), while the FY2024 annual figure was $6.7 million, up 21.95% from the prior year.
• Work In Process for Q1 2025 stood at $8.7 million, up from $6.7 million in the prior quarter.
• The five-year high for Work In Process was $8.7 million in Q1 2025, with the low at $954000.0 in Q2 2021.
• The 5-year median for Work In Process is $3.9 million (2022), against an average of $4.4 million.
• The sharpest annual moves came in 2021 and 2022: Work In Process plunged 72.52% in 2021, then soared 311.64% in 2022.
• Ionis Pharmaceuticals' Work In Process stood at $5.8 million in 2021, then sank by 63.45% to $2.1 million in 2022, then soared by 159.7% to $5.5 million in 2023, then grew by 21.95% to $6.7 million in 2024, then jumped by 30.92% to $8.7 million in 2025.
• Business Quant data shows IONS's Work In Process at $8.7 million in Q1 2025, $6.7 million in Q4 2024, and $6.7 million in Q3 2024.